Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SynPro-15G
- Development stage
- Phase 1
- Lead developer
- Synbio Tech
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
SynPro-15G is a multi-strain probiotic dietary supplement developed for the management of gastrointestinal health and the restoration of a balanced gut microbiome. Developed by Synbio Tech, the formulation typically contains a proprietary blend of 15 distinct probiotic strains, including various species of *Lactobacillus*, *Bifidobacterium*, and *Streptococcus*, delivering approximately 15 billion colony-forming units (CFUs) per dose. Its mechanism of action involves the competitive exclusion of pathogenic bacteria, the reinforcement of the intestinal epithelial barrier, and the modulation of the mucosal immune system. By populating the digestive tract with beneficial flora, SynPro-15G aims to alleviate symptoms of dysbiosis, improve bowel regularity, and support overall metabolic and immune function.
- Brand names
- SynPro-15GSynPro15GSynPro 15G
- Other names
- 15-strain probiotic blend
Beyond the preview
Go deeper on SynPro-15G.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SynPro-15G.